Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

The expression of stem cell-related indicators as a prognostic factor in human lung adenocarcinoma.

Zhang XY, Dong QG, Huang JS, Huang AM, Shi CL, Jin B, Sha HF, Feng JX, Geng Q, Zhou J, Xu HL, Han BH.

J Surg Oncol. 2010 Dec 1;102(7):856-62. doi: 10.1002/jso.21718.

PMID:
20818602
2.

Prognostic significance of OCT4 expression in adenocarcinoma of the lung.

Zhang X, Han B, Huang J, Zheng B, Geng Q, Aziz F, Dong Q.

Jpn J Clin Oncol. 2010 Oct;40(10):961-6. doi: 10.1093/jjco/hyq066. Epub 2010 May 12.

PMID:
20462980
3.

[Lung adenocarcinoma stem cell phenotypes and their correlation with patient prognosis].

Zhang XY, Zheng BQ, Han BH, Huang JS, Geng Q, Xu HL, Zhou J, Dong QG.

Zhonghua Zhong Liu Za Zhi. 2009 Nov;31(11):836-40. Chinese.

PMID:
20137348
4.

IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance.

Zhang X, Sun J, Wang H, Lou Y, Zhang Y, Sha H, Feng J, Han B.

Tumour Biol. 2014 Jan;35(1):739-45. doi: 10.1007/s13277-013-1100-9. Epub 2013 Aug 29.

PMID:
23990442
5.

[Correlations between OCT4 expression and clinicopathological factors and prognosis of patients with lung adenocarcinoma].

Zhang X, Wang H, Jin B, Dong Q, Huang J, Han B.

Zhongguo Fei Ai Za Zhi. 2013 Apr;16(4):197-202. doi: 10.3779/j.issn.1009-3419.2013.04.05. Chinese.

6.

[Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].

Lin MX, Wen ZF, Feng ZY, He D.

Ai Zheng. 2008 Dec;27(12):1321-6. Chinese.

PMID:
19080002
7.

Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1.

Arnes JB, Collett K, Akslen LA.

Histopathology. 2008 Feb;52(3):370-80. doi: 10.1111/j.1365-2559.2007.02957.x.

PMID:
18269588
8.

Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma.

Liu WL, Guo XZ, Zhang LJ, Wang JY, Zhang G, Guan S, Chen YM, Kong QL, Xu LH, Li MZ, Song LB, Zeng MS.

BMC Cancer. 2010 Sep 1;10:467. doi: 10.1186/1471-2407-10-467.

9.

Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.

Häyry V, Mäkinen LK, Atula T, Sariola H, Mäkitie A, Leivo I, Keski-Säntti H, Lundin J, Haglund C, Hagström J.

Br J Cancer. 2010 Mar 2;102(5):892-7. doi: 10.1038/sj.bjc.6605544. Epub 2010 Feb 9.

10.

shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis.

Meng X, Wang Y, Zheng X, Liu C, Su B, Nie H, Zhao B, Zhao X, Yang H.

Lung Cancer. 2012 Jul;77(1):24-30. doi: 10.1016/j.lungcan.2012.02.015. Epub 2012 Mar 13.

PMID:
22420951
11.

[Expression and clinical significance of Bmi-1 protein in bladder cancer].

Qin ZK, Yang JA, Zeng MS, Zhou FJ, Han H, Liu ZW, Yu SL, Li YH, Chen ZF.

Ai Zheng. 2008 Dec;27(12):1327-30. Chinese.

PMID:
19080003
12.

Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.

Kikuchi J, Kinoshita I, Shimizu Y, Kikuchi E, Konishi J, Oizumi S, Kaga K, Matsuno Y, Nishimura M, Dosaka-Akita H.

Cancer. 2010 Jun 15;116(12):3015-24. doi: 10.1002/cncr.25128.

13.

Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study.

Vrzalikova K, Skarda J, Ehrmann J, Murray PG, Fridman E, Kopolovic J, Knizetova P, Hajduch M, Klein J, Kolek V, Radova L, Kolar Z.

J Cancer Res Clin Oncol. 2008 Sep;134(9):1037-42. doi: 10.1007/s00432-008-0361-y. Epub 2008 Feb 9.

PMID:
18264721
14.

Prognostic significance of TAZ expression in resected non-small cell lung cancer.

Xie M, Zhang L, He CS, Hou JH, Lin SX, Hu ZH, Xu F, Zhao HY.

J Thorac Oncol. 2012 May;7(5):799-807. doi: 10.1097/JTO.0b013e318248240b.

15.

Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.

Jacobsen B, Muley T, Meister M, Dienemann H, Christensen IJ, Santoni-Rugiu E, Lærum OD, Ploug M.

J Thorac Oncol. 2013 Feb;8(2):152-60. doi: 10.1097/JTO.0b013e318279d503.

16.

Correlation of Bmi-1 expression and telomerase activity in human ovarian cancer.

Zhang FB, Sui LH, Xin T.

Br J Biomed Sci. 2008;65(4):172-7.

PMID:
19181034
17.

Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.

Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, Sihoe AD, Fink LM, Ma Y, Wong MP.

PLoS One. 2010 Nov 19;5(11):e14062. doi: 10.1371/journal.pone.0014062.

18.

Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.

Donnem T, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM.

J Thorac Oncol. 2009 May;4(5):578-85. doi: 10.1097/JTO.0b013e31819f2e38.

19.

Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).

Grossi F, Spizzo R, Bordo D, Cacitti V, Valent F, Rossetto C, Follador A, Di Terlizzi S, Aita M, Morelli A, Fasola G, Consiglieri C, Ceschia T, Beltrami CA, Belvedere O.

J Thorac Oncol. 2010 Sep;5(9):1354-60. doi: 10.1097/JTO.0b013e3181e77a78.

20.

Expression of nucleolar protein p120 predicts poor prognosis in patients with stage I lung adenocarcinoma.

Saijo Y, Sato G, Usui K, Sato M, Sagawa M, Kondo T, Minami Y, Nukiwa T.

Ann Oncol. 2001 Aug;12(8):1121-5.

PMID:
11583194

Supplemental Content

Support Center